Peter Hopkins

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini et al. · New England Journal of Medicine · 2014 · 3.9K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Reestablishment of Recipient-associated Microbiota in the Lung Allograft Is Linked to Reduced Risk of Bronchiolitis Obliterans Syndrome

Dana Willner, Philip Hugenholtz, Stephanie T. Yerkovich et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 155 citations

Life Sciences, Microbiology, Medical Microbiology +16

Health‐related quality of life in idiopathic pulmonary fibrosis: Data from the <scp>A</scp>ustralian <scp>IPF R</scp>egistry

Ian Glaspole, Sally Chapman, Wendy A. Cooper et al. · Respirology · 2017 · 124 citations · Full text

Pharmacy, Clinical Sciences, Internal Medicine +17

Autologous Adoptive T-cell Therapy for Recurrent or Drug-resistant Cytomegalovirus Complications in Solid Organ Transplant Recipients: A Single-arm Open-label Phase I Clinical Trial

Corey Smith, Leone Beagley, Sweera Rehan et al. · Clinical Infectious Diseases · 2018 · 103 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*

Adelle S. Jee, Robert Sheehy, Peter Hopkins et al. · Respirology · 2020 · 88 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12